2023-2029 Global Gastric Motility Drugs Industry Research & Trends Analysis Report
Gastric motility drugs, also known as prokinetic drugs, are drugs that promote the forward movement of gastrointestinal contents. When gastric motility is low, the emptying of gastric contents is delayed, which can cause many gastrointestinal diseases, such as nausea, vomiting, heartburn, postprandial discomfort, dyspepsia, etc., and can cause gastroesophageal reflux, leading to esophageal ulcer. Gastric motility drugs are used clinically to treat related diseases, such as reflux symptoms, reflux esophagitis, dyspepsia, intestinal obstruction and other common diseases.
This report aims to provide a comprehensive study of the global market for Gastric Motility Drugs. Report Highlights:
(1) Global Gastric Motility Drugs market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Gastric Motility Drugs market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Gastric Motility Drugs market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Gastric Motility Drugs segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Gastric Motility Drugs segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Gastric Motility Drugs, capacity, production and trends.
(7) Gastric Motility Drugs industry supply chain, upstream, midstream and downstream analysis.
According to YH Research, the global market for Gastric Motility Drugs should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Gastric Motility Drugs market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Gastric Motility Drugs market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Monotherapy segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Chronic Gastritis has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Gastric Motility Drugs include Johnson & Johnson, Sumitomo Dainippon, Sanofi, Pfizer, Teva, GrupoFarma, Abbott, Kyowa Kirin and Sigma-Tau Group, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Monotherapy
Poly Pill
Market segment by application, can be divided into
Chronic Gastritis
Reflux Esophagitis
Functional Dyspepsia
Others
Market segment by players, this report covers
Johnson & Johnson
Sumitomo Dainippon
Sanofi
Pfizer
Teva
GrupoFarma
Abbott
Kyowa Kirin
Sigma-Tau Group
Wilmington
Chengdu Kanghong Pharmaceutical Group Co.,Ltd
Lunan Pharmaceutical Group Corporation
Hansoh Pharmaceutical Group Company Limited
Shanghai Sine Pharmaceutical Laboratories Co., Ltd
Disha Pharmaceutical Group Co., Ltd
Xian Janssen Pharmaceutical Ltd
1 Market Overview
1.1 Gastric Motility Drugs Definition
1.2 Global Gastric Motility Drugs Market Size and Forecast
1.2.1 By Revenue, Global Gastric Motility Drugs Market Size, 2018-2029
1.2.2 By Sales Volume, Global Gastric Motility Drugs Market Size, 2018-2029
1.2.3 Global Gastric Motility Drugs Price Trend, 2018-2029
1.3 China Gastric Motility Drugs Market Size and Forecast
1.3.1 By Revenue, China Gastric Motility Drugs Market Size, 2018-2029
1.3.2 By Sales Volume, China Gastric Motility Drugs Market Size, 2018-2029
1.3.3 China Gastric Motility Drugs Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Gastric Motility Drugs Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Gastric Motility Drugs Share in Global Market, 2018-2029
1.4.3 Gastric Motility Drugs Market Size: China VS Global, 2018-2029
1.5 Gastric Motility Drugs Market Dynamics
1.5.1 Gastric Motility Drugs Market Drivers
1.5.2 Gastric Motility Drugs Market Restraints
1.5.3 Gastric Motility Drugs Industry Trends
1.5.4 Gastric Motility Drugs Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Gastric Motility Drugs Revenue by Company, 2018-2023
2.2 Global Gastric Motility Drugs Sales Volume by Company, 2018-2023
2.3 Global Gastric Motility Drugs Price by Company, 2018-2023
2.4 Global Gastric Motility Drugs Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Gastric Motility Drugs Concentration Ratio
2.6 Global Gastric Motility Drugs Mergers & Acquisitions, Expansion Plans
2.7 Global Gastric Motility Drugs Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Gastric Motility Drugs Revenue by Company, 2018-2023
3.2 China Gastric Motility Drugs Sales Volume by Company, 2018-2023
3.3 China Gastric Motility Drugs Gastric Motility Drugs Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Gastric Motility Drugs Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Gastric Motility Drugs Domestic VS Export
3.6 China Market, Gastric Motility Drugs Import & Export
3.6.1 China Market, Gastric Motility Drugs Import & Export, 2018-2029
3.6.2 China Gastric Motility Drugs Import & Export Trends
3.6.3 Main Sources of China Gastric Motility Drugs Import
3.6.4 Export Destination of China Gastric Motility Drugs
4 Gastric Motility Drugs Production by Region
4.1 Global Gastric Motility Drugs Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Gastric Motility Drugs Manufacturers
4.3 Global Major Manufacturers, Gastric Motility Drugs Capacity Expansion and Future Plans
4.4 Global Gastric Motility Drugs Capacity by Region
4.5 Global Gastric Motility Drugs Production by Region
4.5.1 Global Gastric Motility Drugs Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Gastric Motility Drugs Production by Region, 2018-2023
4.5.3 Global Gastric Motility Drugs Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Gastric Motility Drugs Industry Chain
5.2 Gastric Motility Drugs Upstream Analysis
5.2.1 Gastric Motility Drugs Core Raw Materials
5.2.2 Main Manufacturers of Gastric Motility Drugs Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Gastric Motility Drugs Production Mode
5.6 Gastric Motility Drugs Procurement Model
5.7 Gastric Motility Drugs Industry Sales Model and Sales Channels
5.7.1 Gastric Motility Drugs Sales Model
5.7.2 Gastric Motility Drugs Typical Distributors
6 Sights by Type
6.1 Gastric Motility Drugs Classification
6.1.1 Monotherapy
6.1.2 Poly Pill
6.2 By Type, Global Gastric Motility Drugs Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Gastric Motility Drugs Revenue, 2018-2029
6.4 By Type, Global Gastric Motility Drugs Sales Volume, 2018-2029
6.5 By Type, Global Gastric Motility Drugs Price, 2018-2029
7 Sights by Application
7.1 Gastric Motility Drugs Segment by Application
7.1.1 Chronic Gastritis
7.1.2 Reflux Esophagitis
7.1.3 Functional Dyspepsia
7.1.4 Others
7.2 By Application, Global Gastric Motility Drugs Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Gastric Motility Drugs Revenue, 2018-2029
7.4 By Application, Global Gastric Motility Drugs Sales Volume, 2018-2029
7.5 By Application, Global Gastric Motility Drugs Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Gastric Motility Drugs Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Gastric Motility Drugs Revenue, 2018-2029
8.3 By Region, Global Gastric Motility Drugs Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Gastric Motility Drugs Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Gastric Motility Drugs Market Size Market Share
8.5 Europe
8.5.1 Europe Gastric Motility Drugs Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Gastric Motility Drugs Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Gastric Motility Drugs Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Gastric Motility Drugs Market Size Market Share
8.7 South America
8.7.1 South America Gastric Motility Drugs Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Gastric Motility Drugs Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Gastric Motility Drugs Market Size & CAGR，2018 VS 2022 VS 2029
9.2 By Country, Global Gastric Motility Drugs Revenue, 2018-2029
9.3 By Country, Global Gastric Motility Drugs Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Gastric Motility Drugs Market Size, 2018-2029
9.4.2 By Company, U.S. Gastric Motility Drugs Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Gastric Motility Drugs Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Gastric Motility Drugs Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Gastric Motility Drugs Market Size, 2018-2029
9.5.2 By Company, Europe Gastric Motility Drugs Sales Volume Market Share, 2022
9.5.3 By Type, Europe Gastric Motility Drugs Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Gastric Motility Drugs Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Gastric Motility Drugs Market Size, 2018-2029
9.6.2 By Company, China Gastric Motility Drugs Sales Volume Market Share, 2022
9.6.3 By Type, China Gastric Motility Drugs Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Gastric Motility Drugs Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Gastric Motility Drugs Market Size, 2018-2029
9.7.2 By Company, Japan Gastric Motility Drugs Sales Volume Market Share, 2022
9.7.3 By Type, Japan Gastric Motility Drugs Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Gastric Motility Drugs Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Gastric Motility Drugs Market Size, 2018-2029
9.8.2 By Company, South Korea Gastric Motility Drugs Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Gastric Motility Drugs Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Gastric Motility Drugs Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Gastric Motility Drugs Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Gastric Motility Drugs Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Gastric Motility Drugs Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Gastric Motility Drugs Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Gastric Motility Drugs Market Size, 2018-2029
9.10.2 By Company, India Gastric Motility Drugs Sales Volume Market Share, 2022
9.10.3 By Type, India Gastric Motility Drugs Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Gastric Motility Drugs Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Gastric Motility Drugs Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Gastric Motility Drugs Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Gastric Motility Drugs Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Gastric Motility Drugs Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Johnson & Johnson
10.1.1 Johnson & Johnson Company Information, Head Office, Market Area and Industry Position
10.1.2 Johnson & Johnson Gastric Motility Drugs Models, Specifications and Application
10.1.3 Johnson & Johnson Gastric Motility Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Johnson & Johnson Company Profile and Main Business
10.1.5 Johnson & Johnson Recent Developments
10.2 Sumitomo Dainippon
10.2.1 Sumitomo Dainippon Company Information, Head Office, Market Area and Industry Position
10.2.2 Sumitomo Dainippon Gastric Motility Drugs Models, Specifications and Application
10.2.3 Sumitomo Dainippon Gastric Motility Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Sumitomo Dainippon Company Profile and Main Business
10.2.5 Sumitomo Dainippon Recent Developments
10.3 Sanofi
10.3.1 Sanofi Company Information, Head Office, Market Area and Industry Position
10.3.2 Sanofi Gastric Motility Drugs Models, Specifications and Application
10.3.3 Sanofi Gastric Motility Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Sanofi Company Profile and Main Business
10.3.5 Sanofi Recent Developments
10.4 Pfizer
10.4.1 Pfizer Company Information, Head Office, Market Area and Industry Position
10.4.2 Pfizer Gastric Motility Drugs Models, Specifications and Application
10.4.3 Pfizer Gastric Motility Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Pfizer Company Profile and Main Business
10.4.5 Pfizer Recent Developments
10.5 Teva
10.5.1 Teva Company Information, Head Office, Market Area and Industry Position
10.5.2 Teva Gastric Motility Drugs Models, Specifications and Application
10.5.3 Teva Gastric Motility Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Teva Company Profile and Main Business
10.5.5 Teva Recent Developments
10.6 GrupoFarma
10.6.1 GrupoFarma Company Information, Head Office, Market Area and Industry Position
10.6.2 GrupoFarma Gastric Motility Drugs Models, Specifications and Application
10.6.3 GrupoFarma Gastric Motility Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 GrupoFarma Company Profile and Main Business
10.6.5 GrupoFarma Recent Developments
10.7 Abbott
10.7.1 Abbott Company Information, Head Office, Market Area and Industry Position
10.7.2 Abbott Gastric Motility Drugs Models, Specifications and Application
10.7.3 Abbott Gastric Motility Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Abbott Company Profile and Main Business
10.7.5 Abbott Recent Developments
10.8 Kyowa Kirin
10.8.1 Kyowa Kirin Company Information, Head Office, Market Area and Industry Position
10.8.2 Kyowa Kirin Gastric Motility Drugs Models, Specifications and Application
10.8.3 Kyowa Kirin Gastric Motility Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Kyowa Kirin Company Profile and Main Business
10.8.5 Kyowa Kirin Recent Developments
10.9 Sigma-Tau Group
10.9.1 Sigma-Tau Group Company Information, Head Office, Market Area and Industry Position
10.9.2 Sigma-Tau Group Gastric Motility Drugs Models, Specifications and Application
10.9.3 Sigma-Tau Group Gastric Motility Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Sigma-Tau Group Company Profile and Main Business
10.9.5 Sigma-Tau Group Recent Developments
10.10 Wilmington
10.10.1 Wilmington Company Information, Head Office, Market Area and Industry Position
10.10.2 Wilmington Gastric Motility Drugs Models, Specifications and Application
10.10.3 Wilmington Gastric Motility Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Wilmington Company Profile and Main Business
10.10.5 Wilmington Recent Developments
10.11 Chengdu Kanghong Pharmaceutical Group Co.,Ltd
10.11.1 Chengdu Kanghong Pharmaceutical Group Co.,Ltd Company Information, Head Office, Market Area and Industry Position
10.11.2 Chengdu Kanghong Pharmaceutical Group Co.,Ltd Gastric Motility Drugs Models, Specifications and Application
10.11.3 Chengdu Kanghong Pharmaceutical Group Co.,Ltd Gastric Motility Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Chengdu Kanghong Pharmaceutical Group Co.,Ltd Company Profile and Main Business
10.11.5 Chengdu Kanghong Pharmaceutical Group Co.,Ltd Recent Developments
10.12 Lunan Pharmaceutical Group Corporation
10.12.1 Lunan Pharmaceutical Group Corporation Company Information, Head Office, Market Area and Industry Position
10.12.2 Lunan Pharmaceutical Group Corporation Gastric Motility Drugs Models, Specifications and Application
10.12.3 Lunan Pharmaceutical Group Corporation Gastric Motility Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Lunan Pharmaceutical Group Corporation Company Profile and Main Business
10.12.5 Lunan Pharmaceutical Group Corporation Recent Developments
10.13 Hansoh Pharmaceutical Group Company Limited
10.13.1 Hansoh Pharmaceutical Group Company Limited Company Information, Head Office, Market Area and Industry Position
10.13.2 Hansoh Pharmaceutical Group Company Limited Gastric Motility Drugs Models, Specifications and Application
10.13.3 Hansoh Pharmaceutical Group Company Limited Gastric Motility Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Hansoh Pharmaceutical Group Company Limited Company Profile and Main Business
10.13.5 Hansoh Pharmaceutical Group Company Limited Recent Developments
10.14 Shanghai Sine Pharmaceutical Laboratories Co., Ltd
10.14.1 Shanghai Sine Pharmaceutical Laboratories Co., Ltd Company Information, Head Office, Market Area and Industry Position
10.14.2 Shanghai Sine Pharmaceutical Laboratories Co., Ltd Gastric Motility Drugs Models, Specifications and Application
10.14.3 Shanghai Sine Pharmaceutical Laboratories Co., Ltd Gastric Motility Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Shanghai Sine Pharmaceutical Laboratories Co., Ltd Company Profile and Main Business
10.14.5 Shanghai Sine Pharmaceutical Laboratories Co., Ltd Recent Developments
10.15 Disha Pharmaceutical Group Co., Ltd
10.15.1 Disha Pharmaceutical Group Co., Ltd Company Information, Head Office, Market Area and Industry Position
10.15.2 Disha Pharmaceutical Group Co., Ltd Gastric Motility Drugs Models, Specifications and Application
10.15.3 Disha Pharmaceutical Group Co., Ltd Gastric Motility Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Disha Pharmaceutical Group Co., Ltd Company Profile and Main Business
10.15.5 Disha Pharmaceutical Group Co., Ltd Recent Developments
10.16 Xian Janssen Pharmaceutical Ltd
10.16.1 Xian Janssen Pharmaceutical Ltd Company Information, Head Office, Market Area and Industry Position
10.16.2 Xian Janssen Pharmaceutical Ltd Gastric Motility Drugs Models, Specifications and Application
10.16.3 Xian Janssen Pharmaceutical Ltd Gastric Motility Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.16.4 Xian Janssen Pharmaceutical Ltd Company Profile and Main Business
10.16.5 Xian Janssen Pharmaceutical Ltd Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Tables and Figures
Table 1. Gastric Motility Drugs Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Gastric Motility Drugs Market Restraints
Table 3. Gastric Motility Drugs Market Trends
Table 4. Gastric Motility Drugs Industry Policy
Table 5. Global Gastric Motility Drugs Revenue by Company, 2018-2023, US$ million
Table 6. Global Gastric Motility Drugs Revenue Market Share by Company, 2018-2023
Table 7. Global Gastric Motility Drugs Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global Gastric Motility Drugs Sales Volume Market Share by Company, 2018-2023
Table 9. Global Gastric Motility Drugs Price by Company, 2018-2023, (US$/Unit)
Table 10. Global Gastric Motility Drugs Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Gastric Motility Drugs Mergers & Acquisitions, Expansion Plans
Table 12. Global Gastric Motility Drugs Manufacturers Product Type
Table 13. China Gastric Motility Drugs Revenue by Company, 2018-2023, US$ million
Table 14. China Gastric Motility Drugs Revenue Market Share by Company, 2018-2023
Table 15. China Gastric Motility Drugs Sales Volume by Company, 2018-2023, (K Units)
Table 16. China Gastric Motility Drugs Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Gastric Motility Drugs Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China Gastric Motility Drugs Import & Export Trends
Table 19. Main Sources of China Gastric Motility Drugs Import
Table 20. Export Destination of China Gastric Motility Drugs
Table 21. Global Headquarters and Manufacturing Base of Gastric Motility Drugs Manufacturers
Table 22. Global Major Manufacturers, Gastric Motility Drugs Capacity Expansion and Future Plans
Table 23. Global Gastric Motility Drugs Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global Gastric Motility Drugs Production by Region, 2018-2023, (K Units)
Table 25. Global Gastric Motility Drugs Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of Gastric Motility Drugs Upstream (Raw Materials)
Table 27. Global Gastric Motility Drugs Typical Customers
Table 28. Gastric Motility Drugs Typical Distributors
Table 29. By Type, Global Gastric Motility Drugs Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Gastric Motility Drugs Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Gastric Motility Drugs Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Gastric Motility Drugs Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Gastric Motility Drugs Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global Gastric Motility Drugs Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Gastric Motility Drugs Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Gastric Motility Drugs Revenue Market Share, 2018-2029
Table 37. By Country, Global Gastric Motility Drugs Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global Gastric Motility Drugs Sales Volume Market Share, 2018-2029
Table 39. Johnson & Johnson Company Information, Head Office, Market Area and Industry Position
Table 40. Johnson & Johnson Gastric Motility Drugs Models, Specifications and Application
Table 41. Johnson & Johnson Gastric Motility Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Johnson & Johnson Company Profile and Main Business
Table 43. Johnson & Johnson Recent Developments
Table 44. Sumitomo Dainippon Company Information, Head Office, Market Area and Industry Position
Table 45. Sumitomo Dainippon Gastric Motility Drugs Models, Specifications and Application
Table 46. Sumitomo Dainippon Gastric Motility Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Sumitomo Dainippon Company Profile and Main Business
Table 48. Sumitomo Dainippon Recent Developments
Table 49. Sanofi Company Information, Head Office, Market Area and Industry Position
Table 50. Sanofi Gastric Motility Drugs Models, Specifications and Application
Table 51. Sanofi Gastric Motility Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Sanofi Company Profile and Main Business
Table 53. Sanofi Recent Developments
Table 54. Pfizer Company Information, Head Office, Market Area and Industry Position
Table 55. Pfizer Gastric Motility Drugs Models, Specifications and Application
Table 56. Pfizer Gastric Motility Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Pfizer Company Profile and Main Business
Table 58. Pfizer Recent Developments
Table 59. Teva Company Information, Head Office, Market Area and Industry Position
Table 60. Teva Gastric Motility Drugs Models, Specifications and Application
Table 61. Teva Gastric Motility Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Teva Company Profile and Main Business
Table 63. Teva Recent Developments
Table 64. GrupoFarma Company Information, Head Office, Market Area and Industry Position
Table 65. GrupoFarma Gastric Motility Drugs Models, Specifications and Application
Table 66. GrupoFarma Gastric Motility Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. GrupoFarma Company Profile and Main Business
Table 68. GrupoFarma Recent Developments
Table 69. Abbott Company Information, Head Office, Market Area and Industry Position
Table 70. Abbott Gastric Motility Drugs Models, Specifications and Application
Table 71. Abbott Gastric Motility Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Abbott Company Profile and Main Business
Table 73. Abbott Recent Developments
Table 74. Kyowa Kirin Company Information, Head Office, Market Area and Industry Position
Table 75. Kyowa Kirin Gastric Motility Drugs Models, Specifications and Application
Table 76. Kyowa Kirin Gastric Motility Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Kyowa Kirin Company Profile and Main Business
Table 78. Kyowa Kirin Recent Developments
Table 79. Sigma-Tau Group Company Information, Head Office, Market Area and Industry Position
Table 80. Sigma-Tau Group Gastric Motility Drugs Models, Specifications and Application
Table 81. Sigma-Tau Group Gastric Motility Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Sigma-Tau Group Company Profile and Main Business
Table 83. Sigma-Tau Group Recent Developments
Table 84. Wilmington Company Information, Head Office, Market Area and Industry Position
Table 85. Wilmington Gastric Motility Drugs Models, Specifications and Application
Table 86. Wilmington Gastric Motility Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Wilmington Company Profile and Main Business
Table 88. Wilmington Recent Developments
Table 89. Chengdu Kanghong Pharmaceutical Group Co.,Ltd Company Information, Head Office, Market Area and Industry Position
Table 90. Chengdu Kanghong Pharmaceutical Group Co.,Ltd Gastric Motility Drugs Models, Specifications and Application
Table 91. Chengdu Kanghong Pharmaceutical Group Co.,Ltd Gastric Motility Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Chengdu Kanghong Pharmaceutical Group Co.,Ltd Company Profile and Main Business
Table 93. Chengdu Kanghong Pharmaceutical Group Co.,Ltd Recent Developments
Table 94. Lunan Pharmaceutical Group Corporation Company Information, Head Office, Market Area and Industry Position
Table 95. Lunan Pharmaceutical Group Corporation Gastric Motility Drugs Models, Specifications and Application
Table 96. Lunan Pharmaceutical Group Corporation Gastric Motility Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Lunan Pharmaceutical Group Corporation Company Profile and Main Business
Table 98. Lunan Pharmaceutical Group Corporation Recent Developments
Table 99. Hansoh Pharmaceutical Group Company Limited Company Information, Head Office, Market Area and Industry Position
Table 100. Hansoh Pharmaceutical Group Company Limited Gastric Motility Drugs Models, Specifications and Application
Table 101. Hansoh Pharmaceutical Group Company Limited Gastric Motility Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Hansoh Pharmaceutical Group Company Limited Company Profile and Main Business
Table 103. Hansoh Pharmaceutical Group Company Limited Recent Developments
Table 104. Shanghai Sine Pharmaceutical Laboratories Co., Ltd Company Information, Head Office, Market Area and Industry Position
Table 105. Shanghai Sine Pharmaceutical Laboratories Co., Ltd Gastric Motility Drugs Models, Specifications and Application
Table 106. Shanghai Sine Pharmaceutical Laboratories Co., Ltd Gastric Motility Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Shanghai Sine Pharmaceutical Laboratories Co., Ltd Company Profile and Main Business
Table 108. Shanghai Sine Pharmaceutical Laboratories Co., Ltd Recent Developments
Table 109. Disha Pharmaceutical Group Co., Ltd Company Information, Head Office, Market Area and Industry Position
Table 110. Disha Pharmaceutical Group Co., Ltd Gastric Motility Drugs Models, Specifications and Application
Table 111. Disha Pharmaceutical Group Co., Ltd Gastric Motility Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 112. Disha Pharmaceutical Group Co., Ltd Company Profile and Main Business
Table 113. Disha Pharmaceutical Group Co., Ltd Recent Developments
Table 114. Xian Janssen Pharmaceutical Ltd Company Information, Head Office, Market Area and Industry Position
Table 115. Xian Janssen Pharmaceutical Ltd Gastric Motility Drugs Models, Specifications and Application
Table 116. Xian Janssen Pharmaceutical Ltd Gastric Motility Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 117. Xian Janssen Pharmaceutical Ltd Company Profile and Main Business
Table 118. Xian Janssen Pharmaceutical Ltd Recent Developments
List of Figure
Figure 1. Gastric Motility Drugs Picture
Figure 2. By Revenue, Global Gastric Motility Drugs Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global Gastric Motility Drugs Market Size and Forecast, 2018-2029, (K Units)
Figure 4. Global Gastric Motility Drugs Price Trend, 2018-2029, (US$/Unit)
Figure 5. By Revenue, China Gastric Motility Drugs Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China Gastric Motility Drugs Market Size and Forecast, 2018-2029, (K Units)
Figure 7. China Gastric Motility Drugs Price Trend, 2018-2029 (US$/Unit)
Figure 8. By Revenue, China Gastric Motility Drugs Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China Gastric Motility Drugs Share of Global Market, 2018-2029
Figure 10. Global Gastric Motility Drugs Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Gastric Motility Drugs Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Gastric Motility Drugs Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Gastric Motility Drugs Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Gastric Motility Drugs Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of Gastric Motility Drugs Domestic VS Export, 2022
Figure 16. Global Gastric Motility Drugs Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global Gastric Motility Drugs Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Gastric Motility Drugs Production Market Share & Forecast by Region, 2018-2029
Figure 19. Gastric Motility Drugs Industry Chain
Figure 20. Gastric Motility Drugs Procurement Model
Figure 21. Gastric Motility Drugs Sales Model
Figure 22. Gastric Motility Drugs Sales Channels, Direct Sales and Distribution
Figure 23. Monotherapy
Figure 24. Poly Pill
Figure 25. By Type, Global Gastric Motility Drugs Revenue, 2018-2029, US$ Million
Figure 26. By Type, Global Gastric Motility Drugs Revenue Market Share, 2018-2029
Figure 27. By Type, Global Gastric Motility Drugs Sales Volume, 2018-2029, (K Units)
Figure 28. By Type, Global Gastric Motility Drugs Sales Volume Market Share, 2018-2029
Figure 29. By Type, Global Gastric Motility Drugs Price, 2018-2029, (US$/Unit)
Figure 30. Chronic Gastritis
Figure 31. Reflux Esophagitis
Figure 32. Functional Dyspepsia
Figure 33. Others
Figure 34. By Application, Global Gastric Motility Drugs Revenue, 2018-2029, US$ Million
Figure 35. By Application, Global Gastric Motility Drugs Revenue Market Share, 2018-2029
Figure 36. By Application, Global Gastric Motility Drugs Sales Volume, 2018-2029, (K Units)
Figure 37. By Application, Global Gastric Motility Drugs Sales Volume Market Share, 2018-2029
Figure 38. By Application, Global Gastric Motility Drugs Price, 2018-2029, (US$/Unit)
Figure 39. By Region, Global Gastric Motility Drugs Revenue Market Share, 2018-2029
Figure 40. By Region, Global Gastric Motility Drugs Sales Volume Market Share, 2018-2029
Figure 41. North America Gastric Motility Drugs Revenue & Forecasts, 2018-2029, US$ Million
Figure 42. By Country, North America Gastric Motility Drugs Revenue Market Share, 2022
Figure 43. Europe Gastric Motility Drugs Revenue & Forecasts, 2018-2029, US$ Million
Figure 44. By Country, Europe Gastric Motility Drugs Revenue Market Share, 2022
Figure 45. Asia Pacific Gastric Motility Drugs Revenue & Forecasts, 2018-2029, US$ Million
Figure 46. By Country/Region, Asia Pacific Gastric Motility Drugs Revenue Market Share, 2022
Figure 47. South America Gastric Motility Drugs Revenue & Forecasts, 2018-2029, US$ Million
Figure 48. By Country, South America Gastric Motility Drugs Revenue Market Share, 2022
Figure 49. Middle East & Africa Gastric Motility Drugs Revenue & Forecasts, 2018-2029, US$ Million
Figure 50. U.S. Gastric Motility Drugs Sales Volume, 2018-2029, (K Units)
Figure 51. By Company, U.S. Gastric Motility Drugs Market Share, 2022
Figure 52. By Type, U.S. Gastric Motility Drugs Sales Volume Market Share, 2022 VS 2029
Figure 53. By Application, U.S. Gastric Motility Drugs Sales Volume Market Share, 2022 VS 2029
Figure 54. Europe Gastric Motility Drugs Sales Volume, 2018-2029, (K Units)
Figure 55. By Company, Europe Gastric Motility Drugs Market Share, 2022
Figure 56. By Type, Europe Gastric Motility Drugs Sales Volume Market Share, 2022 VS 2029
Figure 57. By Application, Europe Gastric Motility Drugs Sales Volume Market Share, 2022 VS 2029
Figure 58. China Gastric Motility Drugs Sales Volume, 2018-2029, (K Units)
Figure 59. By Company, China Gastric Motility Drugs Market Share, 2022
Figure 60. By Type, China Gastric Motility Drugs Sales Volume Market Share, 2022 VS 2029
Figure 61. By Application, China Gastric Motility Drugs Sales Volume Market Share, 2022 VS 2029
Figure 62. Japan Gastric Motility Drugs Sales Volume, 2018-2029, (K Units)
Figure 63. By Company, Japan Gastric Motility Drugs Market Share, 2022
Figure 64. By Type, Japan Gastric Motility Drugs Sales Volume Market Share, 2022 VS 2029
Figure 65. By Application, Japan Gastric Motility Drugs Sales Volume Market Share, 2022 VS 2029
Figure 66. South Korea Gastric Motility Drugs Sales Volume, 2018-2029, (K Units)
Figure 67. By Company, South Korea Gastric Motility Drugs Market Share, 2022
Figure 68. By Type, South Korea Gastric Motility Drugs Sales Volume Market Share, 2022 VS 2029
Figure 69. By Application, South Korea Gastric Motility Drugs Sales Volume Market Share, 2022 VS 2029
Figure 70. Southeast Asia Gastric Motility Drugs Sales Volume, 2018-2029, (K Units)
Figure 71. By Company, Southeast Asia Gastric Motility Drugs Market Share, 2022
Figure 72. By Type, Southeast Asia Gastric Motility Drugs Sales Volume Market Share, 2022 VS 2029
Figure 73. By Application, Southeast Asia Gastric Motility Drugs Sales Volume Market Share, 2022 VS 2029
Figure 74. India Gastric Motility Drugs Sales Volume, 2018-2029, (K Units)
Figure 75. By Company, India Gastric Motility Drugs Market Share, 2022
Figure 76. By Type, India Gastric Motility Drugs Sales Volume Market Share, 2022 VS 2029
Figure 77. By Application, India Gastric Motility Drugs Sales Volume Market Share, 2022 VS 2029
Figure 78. Middle East & Asia Gastric Motility Drugs Sales Volume, 2018-2029, (K Units)
Figure 79. By Company, Middle East & Asia Gastric Motility Drugs Market Share, 2022
Figure 80. By Type, Middle East & Asia Gastric Motility Drugs Sales Volume Market Share, 2022 VS 2029
Figure 81. By Application, Middle East & Asia Gastric Motility Drugs Sales Volume Market Share, 2022 VS 2029
Figure 82. Research Methodology
Figure 83. Breakdown of Primary Interviews
Figure 84. Bottom-up Approaches
Figure 85. Top-down Approaches
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets